Agoracom Blog

Datametrex $ CEO Provides an Update to Shareholders

Posted by AGORACOM-JC at 12:09 PM on Thursday, October 1st, 2020
Webinar logo

Toronto, Ontario–(October 1, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to provide an update to the market and shareholders from its Chief Executive Officer, Marshall Gunter:

“I believe that it is important for our shareholders to understand our achievements and growth plan.

Since our recent Information Circular for Annual General Meeting (AGM) was registered, there has been much confusion on the topic of a potential consolidation of the shares. The ability to consolidate a company’s share float has been used by many public companies in the past to elevate itself to a larger exchange. Datametrex reserves the right to consolidate our shares, if warranted, for an uplisting to another major exchange. At this time, we do not intend to consolidate the shares nor plan to. We are focused on growing all of the businesses within Datametrex.

We are focused on the expansion of our Artificial Intelligence (AI) business in various verticles. The pace with clients continues to be rapid. This is illustrated with the addition of increased business from global clientele such as LOTTE and 7/11 in South Korea as well as government agencies in both Canada and the United States.

The global markets are demanding seamless solutions to improve their bottom line. We at Datametrex have proven that we enable them to do just that. To have these clients is a real testament to our team of professionals who are working around the clock to secure our future success with our AI suite of services.

We continue to report success within our line of coronavirus solutions. The interest continues to grow, as we have illustrated in our recent press releases. To date, we have been approached by numerous companies across many sectors. I am pleased with what we have achieved.

Our indication of profitability is in a range between 20% and 40%. We deliver secured reporting and testing solutions that are FDA, Health Canada, and CE approved. This gives our clients the capability to support and protect their employees and clients.

Datametrex can adapt and serve the ever-changing coronavirus landscape. It is a terrible situation for our country. We do not take this lightly. I am confident in all the services we are providing. Datametrex will update the market on developments in future communications when material.

We are in the final stages of filing our OTC QB listing in the US. I am glad to state that our filing has been submitted, and our timing is on track with the US regulators.

I thank all of our shareholders who have and continue to support us. We are committed to you. Thank you.”

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy ( Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , , , , ,

Comments are closed.